§ PHARMACEUTICALS
USD · PharmaceuticalsESPR
ESPERION THERAPEUTICS INC
USDSector · PharmaceuticalsBeta · 1.15
§ 01 · PRICE
Price action
1D5D1M6MYTD1YMAX
§ 03 · SIGNAL STACK · WHAT THE INPUTS SAY
13F FLOW
115 increased/new, 54 decreased/exited (13F)
AC 13F Analysis
§ 04 · FUNDAMENTALS · THE BOOKS
| P/B | 81.89 | EPS (TTM) | -0.06 |
§ 05 · WHO OWNS IT
Top institutional holders
| Fund | Shares | % port | Δ Q/Q |
|---|---|---|---|
| BlackRock, Inc. | 17.9M | 0.0% | +1% |
| WASATCH ADVISORS LP | 15.8M | 0.3% | +67% |
| Two Seas Capital LP | 11.4M | 0.4% | −4% |
| ORBIMED ADVISORS LLC | 10.6M | 0.6% | +77% |
| VANGUARD CAPITAL MANAGEMENT LLC | 10.4M | n/a | n/a |
| TWO SIGMA INVESTMENTS, LP | 9.5M | 0.0% | +99% |
◇ AC INTELLIGENCE
Top institutional owners for ESPR as of the most recent 13F reporting period (Q1 2026 · Period ended Mar 31). Δ Q/Q reflects share-count change vs. the prior filing — positive green means adding, negative red means trimming. Cross-reference with the ownership-mix bars below to see which strategy cohort is driving the flow.
§ 06 · WHO OWNS IT · BY STRATEGY
OTHER76.9% · 0 holders
OTHER14.1% · 146 holders
PASSIVE / INDEX3.1% · 9 holders
DEALER / BANK2.8% · 24 holders
SYSTEMATIC / QUANT1.2% · 5 holders
ACTIVIST0.8% · 1 holder
QUALITY / COMPOUNDER0.6% · 10 holders
TACTICAL / MACRO0.2% · 3 holders
INCOME / DEFENSIVE0.2% · 8 holders
GROWTH / MOMENTUM0.0% · 1 holder
◇ AC INTELLIGENCE
Ownership mix by behavioral cohort. Top bars indicate which style of capital dominates the float — passive indexing, quality compounders, dealer/bank, systematic quant, etc. Big quality-compounder share means concentrated active conviction; heavy passive share means flows are dictated by index rebalances, not fundamentals.
§ 07 · INSIDER ACTIVITY · LAST 180 DAYS
NO INSIDER FILINGS
◇ AC INTELLIGENCE
No Form 4 filings on record for ESPR in the last 180 days.
§ 08 · COVERAGE · OUR RECENT NOTES
No notes mention ESPR yet.